Table of Content

1 CNS Oral Drugs Market Overview
1.1 Product Overview and Scope of CNS Oral Drugs
1.2 CNS Oral Drugs Segment by Type
1.2.1 Global CNS Oral Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Antidepressants
1.2.3 Antipsychotics
1.2.4 Anti-Dementia Drugs
1.2.5 Anti-Parkinson's Drugs
1.2.6 Antiepileptic Drugs
1.2.7 Others
1.3 CNS Oral Drugs Segment by Application
1.3.1 Global CNS Oral Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.4 Global CNS Oral Drugs Market Size Estimates and Forecasts
1.4.1 Global CNS Oral Drugs Revenue 2024-2034
1.4.2 Global CNS Oral Drugs Sales 2024-2034
1.4.3 Global CNS Oral Drugs Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 CNS Oral Drugs Market Competition by Manufacturers
2.1 Global CNS Oral Drugs Sales Market Share by Manufacturers (2024-2024)
2.2 Global CNS Oral Drugs Revenue Market Share by Manufacturers (2024-2024)
2.3 Global CNS Oral Drugs Average Price by Manufacturers (2024-2024)
2.4 Global CNS Oral Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of CNS Oral Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CNS Oral Drugs, Product Type & Application
2.7 CNS Oral Drugs Market Competitive Situation and Trends
2.7.1 CNS Oral Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CNS Oral Drugs Players Market Share by Revenue
2.7.3 Global CNS Oral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CNS Oral Drugs Retrospective Market Scenario by Region
3.1 Global CNS Oral Drugs Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global CNS Oral Drugs Global CNS Oral Drugs Sales by Region: 2024-2034
3.2.1 Global CNS Oral Drugs Sales by Region: 2024-2024
3.2.2 Global CNS Oral Drugs Sales by Region: 2024-2034
3.3 Global CNS Oral Drugs Global CNS Oral Drugs Revenue by Region: 2024-2034
3.3.1 Global CNS Oral Drugs Revenue by Region: 2024-2024
3.3.2 Global CNS Oral Drugs Revenue by Region: 2024-2034
3.4 North America CNS Oral Drugs Market Facts & Figures by Country
3.4.1 North America CNS Oral Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America CNS Oral Drugs Sales by Country (2024-2034)
3.4.3 North America CNS Oral Drugs Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe CNS Oral Drugs Market Facts & Figures by Country
3.5.1 Europe CNS Oral Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe CNS Oral Drugs Sales by Country (2024-2034)
3.5.3 Europe CNS Oral Drugs Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CNS Oral Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific CNS Oral Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific CNS Oral Drugs Sales by Country (2024-2034)
3.6.3 Asia Pacific CNS Oral Drugs Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CNS Oral Drugs Market Facts & Figures by Country
3.7.1 Latin America CNS Oral Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America CNS Oral Drugs Sales by Country (2024-2034)
3.7.3 Latin America CNS Oral Drugs Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CNS Oral Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa CNS Oral Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa CNS Oral Drugs Sales by Country (2024-2034)
3.8.3 Middle East and Africa CNS Oral Drugs Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CNS Oral Drugs Sales by Type (2024-2034)
4.1.1 Global CNS Oral Drugs Sales by Type (2024-2024)
4.1.2 Global CNS Oral Drugs Sales by Type (2024-2034)
4.1.3 Global CNS Oral Drugs Sales Market Share by Type (2024-2034)
4.2 Global CNS Oral Drugs Revenue by Type (2024-2034)
4.2.1 Global CNS Oral Drugs Revenue by Type (2024-2024)
4.2.2 Global CNS Oral Drugs Revenue by Type (2024-2034)
4.2.3 Global CNS Oral Drugs Revenue Market Share by Type (2024-2034)
4.3 Global CNS Oral Drugs Price by Type (2024-2034)
5 Segment by Application
5.1 Global CNS Oral Drugs Sales by Application (2024-2034)
5.1.1 Global CNS Oral Drugs Sales by Application (2024-2024)
5.1.2 Global CNS Oral Drugs Sales by Application (2024-2034)
5.1.3 Global CNS Oral Drugs Sales Market Share by Application (2024-2034)
5.2 Global CNS Oral Drugs Revenue by Application (2024-2034)
5.2.1 Global CNS Oral Drugs Revenue by Application (2024-2024)
5.2.2 Global CNS Oral Drugs Revenue by Application (2024-2034)
5.2.3 Global CNS Oral Drugs Revenue Market Share by Application (2024-2034)
5.3 Global CNS Oral Drugs Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Pfizer CNS Oral Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Biogen
6.2.1 Biogen Corporation Information
6.2.2 Biogen Description and Business Overview
6.2.3 Biogen CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Biogen CNS Oral Drugs Product Portfolio
6.2.5 Biogen Recent Developments/Updates
6.3 Otsuka
6.3.1 Otsuka Corporation Information
6.3.2 Otsuka Description and Business Overview
6.3.3 Otsuka CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Otsuka CNS Oral Drugs Product Portfolio
6.3.5 Otsuka Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Novartis CNS Oral Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Corporation Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Teva Pharmaceutical CNS Oral Drugs Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Johnson & Johnson CNS Oral Drugs Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 AstraZeneca CNS Oral Drugs Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Merck CNS Oral Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.9.4 GSK CNS Oral Drugs Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Eli Lilly and Company
6.10.1 Eli Lilly and Company Corporation Information
6.10.2 Eli Lilly and Company Description and Business Overview
6.10.3 Eli Lilly and Company CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Eli Lilly and Company CNS Oral Drugs Product Portfolio
6.10.5 Eli Lilly and Company Recent Developments/Updates
6.11 Lundbeck
6.11.1 Lundbeck Corporation Information
6.11.2 Lundbeck CNS Oral Drugs Description and Business Overview
6.11.3 Lundbeck CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Lundbeck CNS Oral Drugs Product Portfolio
6.11.5 Lundbeck Recent Developments/Updates
6.12 Takeda
6.12.1 Takeda Corporation Information
6.12.2 Takeda CNS Oral Drugs Description and Business Overview
6.12.3 Takeda CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Takeda CNS Oral Drugs Product Portfolio
6.12.5 Takeda Recent Developments/Updates
6.13 Bristol Myers Squibb
6.13.1 Bristol Myers Squibb Corporation Information
6.13.2 Bristol Myers Squibb CNS Oral Drugs Description and Business Overview
6.13.3 Bristol Myers Squibb CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Bristol Myers Squibb CNS Oral Drugs Product Portfolio
6.13.5 Bristol Myers Squibb Recent Developments/Updates
6.14 Jiangsu Nhwa Pharmaceutical
6.14.1 Jiangsu Nhwa Pharmaceutical Corporation Information
6.14.2 Jiangsu Nhwa Pharmaceutical CNS Oral Drugs Description and Business Overview
6.14.3 Jiangsu Nhwa Pharmaceutical CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Jiangsu Nhwa Pharmaceutical CNS Oral Drugs Product Portfolio
6.14.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
6.15 Luye Pharma
6.15.1 Luye Pharma Corporation Information
6.15.2 Luye Pharma CNS Oral Drugs Description and Business Overview
6.15.3 Luye Pharma CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Luye Pharma CNS Oral Drugs Product Portfolio
6.15.5 Luye Pharma Recent Developments/Updates
6.16 Zhejiang Huahai Pharmaceutical
6.16.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.16.2 Zhejiang Huahai Pharmaceutical CNS Oral Drugs Description and Business Overview
6.16.3 Zhejiang Huahai Pharmaceutical CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Zhejiang Huahai Pharmaceutical CNS Oral Drugs Product Portfolio
6.16.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.17 Chengdu Easton Biopharmaceuticals
6.17.1 Chengdu Easton Biopharmaceuticals Corporation Information
6.17.2 Chengdu Easton Biopharmaceuticals CNS Oral Drugs Description and Business Overview
6.17.3 Chengdu Easton Biopharmaceuticals CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Chengdu Easton Biopharmaceuticals CNS Oral Drugs Product Portfolio
6.17.5 Chengdu Easton Biopharmaceuticals Recent Developments/Updates
6.18 Hansoh Pharmaceutical
6.18.1 Hansoh Pharmaceutical Corporation Information
6.18.2 Hansoh Pharmaceutical CNS Oral Drugs Description and Business Overview
6.18.3 Hansoh Pharmaceutical CNS Oral Drugs Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Hansoh Pharmaceutical CNS Oral Drugs Product Portfolio
6.18.5 Hansoh Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CNS Oral Drugs Industry Chain Analysis
7.2 CNS Oral Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CNS Oral Drugs Production Mode & Process
7.4 CNS Oral Drugs Sales and Marketing
7.4.1 CNS Oral Drugs Sales Channels
7.4.2 CNS Oral Drugs Distributors
7.5 CNS Oral Drugs Customers
8 CNS Oral Drugs Market Dynamics
8.1 CNS Oral Drugs Industry Trends
8.2 CNS Oral Drugs Market Drivers
8.3 CNS Oral Drugs Market Challenges
8.4 CNS Oral Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global CNS Oral Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global CNS Oral Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global CNS Oral Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global CNS Oral Drugs Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global CNS Oral Drugs Sales Market Share by Manufacturers (2024-2024)
Table 6. Global CNS Oral Drugs Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global CNS Oral Drugs Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market CNS Oral Drugs Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of CNS Oral Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of CNS Oral Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CNS Oral Drugs, Product Type & Application
Table 12. Global Key Manufacturers of CNS Oral Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CNS Oral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CNS Oral Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CNS Oral Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global CNS Oral Drugs Sales by Region (2024-2024) & (K Units)
Table 18. Global CNS Oral Drugs Sales Market Share by Region (2024-2024)
Table 19. Global CNS Oral Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global CNS Oral Drugs Sales Market Share by Region (2024-2034)
Table 21. Global CNS Oral Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global CNS Oral Drugs Revenue Market Share by Region (2024-2024)
Table 23. Global CNS Oral Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global CNS Oral Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America CNS Oral Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America CNS Oral Drugs Sales by Country (2024-2024) & (K Units)
Table 27. North America CNS Oral Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America CNS Oral Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America CNS Oral Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe CNS Oral Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe CNS Oral Drugs Sales by Country (2024-2024) & (K Units)
Table 32. Europe CNS Oral Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe CNS Oral Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe CNS Oral Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific CNS Oral Drugs Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific CNS Oral Drugs Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific CNS Oral Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific CNS Oral Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific CNS Oral Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America CNS Oral Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America CNS Oral Drugs Sales by Country (2024-2024) & (K Units)
Table 42. Latin America CNS Oral Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America CNS Oral Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America CNS Oral Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa CNS Oral Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa CNS Oral Drugs Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa CNS Oral Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa CNS Oral Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa CNS Oral Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global CNS Oral Drugs Sales (K Units) by Type (2024-2024)
Table 51. Global CNS Oral Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global CNS Oral Drugs Sales Market Share by Type (2024-2024)
Table 53. Global CNS Oral Drugs Sales Market Share by Type (2024-2034)
Table 54. Global CNS Oral Drugs Revenue (US$ Million) by Type (2024-2024)
Table 55. Global CNS Oral Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global CNS Oral Drugs Revenue Market Share by Type (2024-2024)
Table 57. Global CNS Oral Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global CNS Oral Drugs Price (US$/Unit) by Type (2024-2024)
Table 59. Global CNS Oral Drugs Price (US$/Unit) by Type (2024-2034)
Table 60. Global CNS Oral Drugs Sales (K Units) by Application (2024-2024)
Table 61. Global CNS Oral Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global CNS Oral Drugs Sales Market Share by Application (2024-2024)
Table 63. Global CNS Oral Drugs Sales Market Share by Application (2024-2034)
Table 64. Global CNS Oral Drugs Revenue (US$ Million) by Application (2024-2024)
Table 65. Global CNS Oral Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global CNS Oral Drugs Revenue Market Share by Application (2024-2024)
Table 67. Global CNS Oral Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global CNS Oral Drugs Price (US$/Unit) by Application (2024-2024)
Table 69. Global CNS Oral Drugs Price (US$/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Pfizer CNS Oral Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Biogen Corporation Information
Table 76. Biogen Description and Business Overview
Table 77. Biogen CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Biogen CNS Oral Drugs Product
Table 79. Biogen Recent Developments/Updates
Table 80. Otsuka Corporation Information
Table 81. Otsuka Description and Business Overview
Table 82. Otsuka CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Otsuka CNS Oral Drugs Product
Table 84. Otsuka Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Novartis CNS Oral Drugs Product
Table 89. Novartis Recent Developments/Updates
Table 90. Teva Pharmaceutical Corporation Information
Table 91. Teva Pharmaceutical Description and Business Overview
Table 92. Teva Pharmaceutical CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Teva Pharmaceutical CNS Oral Drugs Product
Table 94. Teva Pharmaceutical Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Johnson & Johnson CNS Oral Drugs Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. AstraZeneca CNS Oral Drugs Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Merck CNS Oral Drugs Product
Table 109. Merck Recent Developments/Updates
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. GSK CNS Oral Drugs Product
Table 114. GSK Recent Developments/Updates
Table 115. Eli Lilly and Company Corporation Information
Table 116. Eli Lilly and Company Description and Business Overview
Table 117. Eli Lilly and Company CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Eli Lilly and Company CNS Oral Drugs Product
Table 119. Eli Lilly and Company Recent Developments/Updates
Table 120. Lundbeck Corporation Information
Table 121. Lundbeck Description and Business Overview
Table 122. Lundbeck CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Lundbeck CNS Oral Drugs Product
Table 124. Lundbeck Recent Developments/Updates
Table 125. Takeda Corporation Information
Table 126. Takeda Description and Business Overview
Table 127. Takeda CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Takeda CNS Oral Drugs Product
Table 129. Takeda Recent Developments/Updates
Table 130. Bristol Myers Squibb Corporation Information
Table 131. Bristol Myers Squibb Description and Business Overview
Table 132. Bristol Myers Squibb CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Bristol Myers Squibb CNS Oral Drugs Product
Table 134. Bristol Myers Squibb Recent Developments/Updates
Table 135. Jiangsu Nhwa Pharmaceutical Corporation Information
Table 136. Jiangsu Nhwa Pharmaceutical Description and Business Overview
Table 137. Jiangsu Nhwa Pharmaceutical CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Jiangsu Nhwa Pharmaceutical CNS Oral Drugs Product
Table 139. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 140. Luye Pharma Corporation Information
Table 141. Luye Pharma Description and Business Overview
Table 142. Luye Pharma CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Luye Pharma CNS Oral Drugs Product
Table 144. Luye Pharma Recent Developments/Updates
Table 145. Zhejiang Huahai Pharmaceutical Corporation Information
Table 146. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 147. Zhejiang Huahai Pharmaceutical CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Zhejiang Huahai Pharmaceutical CNS Oral Drugs Product
Table 149. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 150. Chengdu Easton Biopharmaceuticals Corporation Information
Table 151. Chengdu Easton Biopharmaceuticals Description and Business Overview
Table 152. Chengdu Easton Biopharmaceuticals CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Chengdu Easton Biopharmaceuticals CNS Oral Drugs Product
Table 154. Chengdu Easton Biopharmaceuticals Recent Developments/Updates
Table 155. Hansoh Pharmaceutical Corporation Information
Table 156. Hansoh Pharmaceutical Description and Business Overview
Table 157. Hansoh Pharmaceutical CNS Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Hansoh Pharmaceutical CNS Oral Drugs Product
Table 159. Hansoh Pharmaceutical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. CNS Oral Drugs Distributors List
Table 163. CNS Oral Drugs Customers List
Table 164. CNS Oral Drugs Market Trends
Table 165. CNS Oral Drugs Market Drivers
Table 166. CNS Oral Drugs Market Challenges
Table 167. CNS Oral Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of CNS Oral Drugs
Figure 2. Global CNS Oral Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global CNS Oral Drugs Market Share by Type in 2022 & 2034
Figure 4. Antidepressants Product Picture
Figure 5. Antipsychotics Product Picture
Figure 6. Anti-Dementia Drugs Product Picture
Figure 7. Anti-Parkinson's Drugs Product Picture
Figure 8. Antiepileptic Drugs Product Picture
Figure 9. Others Product Picture
Figure 10. Global CNS Oral Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global CNS Oral Drugs Market Share by Application in 2022 & 2034
Figure 12. Hospital and Clinic
Figure 13. Pharmacy
Figure 14. Global CNS Oral Drugs Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global CNS Oral Drugs Market Size (2024-2034) & (US$ Million)
Figure 16. Global CNS Oral Drugs Sales (2024-2034) & (K Units)
Figure 17. Global CNS Oral Drugs Average Price (US$/Unit) & (2024-2034)
Figure 18. CNS Oral Drugs Report Years Considered
Figure 19. CNS Oral Drugs Sales Share by Manufacturers in 2022
Figure 20. Global CNS Oral Drugs Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest CNS Oral Drugs Players: Market Share by Revenue in 2022
Figure 22. CNS Oral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global CNS Oral Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America CNS Oral Drugs Sales Market Share by Country (2024-2034)
Figure 25. North America CNS Oral Drugs Revenue Market Share by Country (2024-2034)
Figure 26. United States CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe CNS Oral Drugs Sales Market Share by Country (2024-2034)
Figure 29. Europe CNS Oral Drugs Revenue Market Share by Country (2024-2034)
Figure 30. Germany CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific CNS Oral Drugs Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific CNS Oral Drugs Revenue Market Share by Region (2024-2034)
Figure 37. China CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. China Taiwan CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Southeast Asia CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Latin America CNS Oral Drugs Sales Market Share by Country (2024-2034)
Figure 45. Latin America CNS Oral Drugs Revenue Market Share by Country (2024-2034)
Figure 46. Mexico CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Brazil CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Argentina CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa CNS Oral Drugs Sales Market Share by Country (2024-2034)
Figure 50. Middle East & Africa CNS Oral Drugs Revenue Market Share by Country (2024-2034)
Figure 51. Turkey CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. UAE CNS Oral Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Global Sales Market Share of CNS Oral Drugs by Type (2024-2034)
Figure 55. Global Revenue Market Share of CNS Oral Drugs by Type (2024-2034)
Figure 56. Global CNS Oral Drugs Price (US$/Unit) by Type (2024-2034)
Figure 57. Global Sales Market Share of CNS Oral Drugs by Application (2024-2034)
Figure 58. Global Revenue Market Share of CNS Oral Drugs by Application (2024-2034)
Figure 59. Global CNS Oral Drugs Price (US$/Unit) by Application (2024-2034)
Figure 60. CNS Oral Drugs Value Chain
Figure 61. CNS Oral Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed